NASDAQ

bioAffinity Technologies Appoints New Senior VP for Research & Development of Therapeutics

SAN ANTONIO, July 07, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced that William ...

Celsion Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

LAWRENCEVILLE, N.J., July 07, 2016 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN) today announced that ...

Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016

DUBLIN, Ireland, July 07, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016

DUBLIN, Ireland, July 07, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016

DUBLIN, Ireland, July 07, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

NewLink Genetics to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference

AMES, Iowa, July 07, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced ...

Heat Biologics Announces “Cancer Immunology Research” Publication Featuring its ComPACT Platform Technology

ComPACT secreting OX40L increased tumor infiltrating lymphocytes in preclinical modelsDURHAM, N.C., July 07, 2016 ...

Oncobiologics, Inc. to Present at the 2016 Cantor Fitzgerald 2nd Annual Healthcare Conference

CRANBURY, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

Nanobiotix reports successful results from Phase I/II Trial of NBTXR3 in Head & Neck Cancer

 Primary safety and feasibility endpoints achieved Preliminary positive signs of antitumoral effect in all ...